Advertisement

Topics

Amgen Breaks Ground On Next-Generation Biomanufacturing Plant In Rhode Island

16:15 EDT 31 Jul 2018 | AMGEN

The Plant Will be First-of-its-Kind in the U.S. THOUSAND OAKS, Calif., July 31, 2018 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced the groundbreaking of its new next-generation biomanufacturing plant that will be constructed at its West Greenwich, R.I. campus. The new plant is the first-of-its-kind in the U.S. and will use Amgen's proven next-generation biomanufacturing capabilities to manufacture products for the U.S. and global markets. "Biologics manufacturing is a complex science and has long been a competitive advantage for Amgen," said Robert A. Bradway, chairman and chief executive officer at Amgen. "We are working to extend that advanta...

Original Article: Amgen Breaks Ground On Next-Generation Biomanufacturing Plant In Rhode Island

NEXT ARTICLE

More From BioPortfolio on "Amgen Breaks Ground On Next-Generation Biomanufacturing Plant In Rhode Island"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Biotherapeutics
The field encompassing therapeutic materials produced using biological means, including recombinant DNA technology. Biotherapeutics, also known as biotech drugs or biologics, are therapies derived from living organisms. By harnessing these living cells...